On the other hand, in chronic lymphocytic leukemia (CLL), large B-lymphoma cells, and multiple myeloma, the antiapoptotic protein Bcl-2 binds the InsP3R, suppressing its activity to prevent cytosolic Ca2+ increase-mediated apoptosis. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.